New Policies Offer Pension Choices To Academic Scientists

Rare is the scientist who embarks on a career in academia purely for the money. On the other hand, money can surely be a key factor in deciding when to leave that career, especially in light of revised pension policies and retirement laws. Consider the following: By working one year beyond the traditional retirement age of 65, a university researcher with 30 years of service conceivably can add as much as $50,000 to his or her pension fund, in addition to collecting a regular annual salary.

Written byJulia King
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Rare is the scientist who embarks on a career in academia purely for the money. On the other hand, money can surely be a key factor in deciding when to leave that career, especially in light of revised pension policies and retirement laws. Consider the following:

Taken together, these and other new provisions in higher education pension plans are cause for university researchers to start planning now for their retirement years. If they don't, university administrators and investment experts say, they could lose out on financial gains that might accrue under the new policies.

"Now is a good opportunity to stop, look, and listen to what's going on with pensions in higher education," says Brian Mattes, vice president of the Vanguard Group, a mutual funds company in Valley Forge, Pa. "Unfortunately, though, most people set up a pension policy and then don't look at it again for another five or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies